nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP1A2—type 2 diabetes mellitus	0.258	0.602	CbGaD
Levobupivacaine—CYP3A4—type 2 diabetes mellitus	0.171	0.398	CbGaD
Levobupivacaine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0387	0.113	CbGbCtD
Levobupivacaine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0341	0.0999	CbGbCtD
Levobupivacaine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0305	0.0893	CbGbCtD
Levobupivacaine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0304	0.089	CbGbCtD
Levobupivacaine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0288	0.0844	CbGbCtD
Levobupivacaine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0278	0.0814	CbGbCtD
Levobupivacaine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0243	0.0712	CbGbCtD
Levobupivacaine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.022	0.0644	CbGbCtD
Levobupivacaine—CYP1A2—Losartan—type 2 diabetes mellitus	0.0197	0.0575	CbGbCtD
Levobupivacaine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0167	0.0488	CbGbCtD
Levobupivacaine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.016	0.0468	CbGbCtD
Levobupivacaine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.016	0.0468	CbGbCtD
Levobupivacaine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0151	0.0442	CbGbCtD
Levobupivacaine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0113	0.0329	CbGbCtD
Levobupivacaine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0103	0.0301	CbGbCtD
Levobupivacaine—Lidocaine—EGFR—type 2 diabetes mellitus	0.00049	0.154	CrCbGaD
Levobupivacaine—Bupivacaine—CYP1A2—type 2 diabetes mellitus	0.000462	0.145	CrCbGaD
Levobupivacaine—Ropivacaine—CYP1A2—type 2 diabetes mellitus	0.000372	0.117	CrCbGaD
Levobupivacaine—Tocainide—CYP1A2—type 2 diabetes mellitus	0.00035	0.11	CrCbGaD
Levobupivacaine—Ranolazine—CYP3A4—type 2 diabetes mellitus	0.000312	0.0977	CrCbGaD
Levobupivacaine—Bupivacaine—CYP3A4—type 2 diabetes mellitus	0.000306	0.0958	CrCbGaD
Levobupivacaine—Lidocaine—CYP1A2—type 2 diabetes mellitus	0.00027	0.0848	CrCbGaD
Levobupivacaine—Ropivacaine—CYP3A4—type 2 diabetes mellitus	0.000246	0.0773	CrCbGaD
Levobupivacaine—Tocainide—ALB—type 2 diabetes mellitus	0.000202	0.0634	CrCbGaD
Levobupivacaine—Lidocaine—CYP3A4—type 2 diabetes mellitus	0.000179	0.0561	CrCbGaD
Levobupivacaine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000117	0.000659	CcSEcCtD
Levobupivacaine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000117	0.000658	CcSEcCtD
Levobupivacaine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000117	0.000658	CcSEcCtD
Levobupivacaine—Hypertension—Metformin—type 2 diabetes mellitus	0.000117	0.000655	CcSEcCtD
Levobupivacaine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000117	0.000655	CcSEcCtD
Levobupivacaine—Nervousness—Losartan—type 2 diabetes mellitus	0.000117	0.000655	CcSEcCtD
Levobupivacaine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000117	0.000655	CcSEcCtD
Levobupivacaine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000117	0.000654	CcSEcCtD
Levobupivacaine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000116	0.000653	CcSEcCtD
Levobupivacaine—Back pain—Losartan—type 2 diabetes mellitus	0.000116	0.000652	CcSEcCtD
Levobupivacaine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000116	0.000652	CcSEcCtD
Levobupivacaine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000116	0.000652	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000116	0.00065	CcSEcCtD
Levobupivacaine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000115	0.000648	CcSEcCtD
Levobupivacaine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000647	CcSEcCtD
Levobupivacaine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000115	0.000643	CcSEcCtD
Levobupivacaine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000114	0.000642	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000114	0.000642	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000114	0.000639	CcSEcCtD
Levobupivacaine—Nausea—Glipizide—type 2 diabetes mellitus	0.000113	0.000636	CcSEcCtD
Levobupivacaine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000113	0.000636	CcSEcCtD
Levobupivacaine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000113	0.000636	CcSEcCtD
Levobupivacaine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000113	0.000635	CcSEcCtD
Levobupivacaine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000113	0.000634	CcSEcCtD
Levobupivacaine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000113	0.000633	CcSEcCtD
Levobupivacaine—Pain—Gliclazide—type 2 diabetes mellitus	0.000113	0.000633	CcSEcCtD
Levobupivacaine—Tremor—Losartan—type 2 diabetes mellitus	0.000113	0.000632	CcSEcCtD
Levobupivacaine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000112	0.00063	CcSEcCtD
Levobupivacaine—Headache—Glimepiride—type 2 diabetes mellitus	0.000112	0.000626	CcSEcCtD
Levobupivacaine—Cough—Irbesartan—type 2 diabetes mellitus	0.000111	0.000625	CcSEcCtD
Levobupivacaine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000111	0.000624	CcSEcCtD
Levobupivacaine—Anaemia—Losartan—type 2 diabetes mellitus	0.000111	0.000623	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00011	0.00062	CcSEcCtD
Levobupivacaine—Agitation—Losartan—type 2 diabetes mellitus	0.00011	0.00062	CcSEcCtD
Levobupivacaine—Oedema—Metformin—type 2 diabetes mellitus	0.00011	0.00062	CcSEcCtD
Levobupivacaine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.00011	0.000619	CcSEcCtD
Levobupivacaine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00011	0.000619	CcSEcCtD
Levobupivacaine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00011	0.000617	CcSEcCtD
Levobupivacaine—Flushing—Ramipril—type 2 diabetes mellitus	0.00011	0.000616	CcSEcCtD
Levobupivacaine—Angioedema—Losartan—type 2 diabetes mellitus	0.00011	0.000616	CcSEcCtD
Levobupivacaine—Infection—Metformin—type 2 diabetes mellitus	0.00011	0.000616	CcSEcCtD
Levobupivacaine—Insomnia—Valsartan—type 2 diabetes mellitus	0.00011	0.000615	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000109	0.000612	CcSEcCtD
Levobupivacaine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000109	0.000611	CcSEcCtD
Levobupivacaine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000109	0.00061	CcSEcCtD
Levobupivacaine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000109	0.00061	CcSEcCtD
Levobupivacaine—Shock—Metformin—type 2 diabetes mellitus	0.000109	0.00061	CcSEcCtD
Levobupivacaine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000108	0.000608	CcSEcCtD
Levobupivacaine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000108	0.000608	CcSEcCtD
Levobupivacaine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000108	0.000608	CcSEcCtD
Levobupivacaine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000108	0.000608	CcSEcCtD
Levobupivacaine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000108	0.000607	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000108	0.000606	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000108	0.000606	CcSEcCtD
Levobupivacaine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000108	0.000605	CcSEcCtD
Levobupivacaine—Syncope—Losartan—type 2 diabetes mellitus	0.000108	0.000605	CcSEcCtD
Levobupivacaine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000108	0.000604	CcSEcCtD
Levobupivacaine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000107	0.000602	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000107	0.000599	CcSEcCtD
Levobupivacaine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000107	0.000599	CcSEcCtD
Levobupivacaine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000597	CcSEcCtD
Levobupivacaine—Palpitations—Losartan—type 2 diabetes mellitus	0.000106	0.000596	CcSEcCtD
Levobupivacaine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000106	0.000594	CcSEcCtD
Levobupivacaine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000106	0.000593	CcSEcCtD
Levobupivacaine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000106	0.000593	CcSEcCtD
Levobupivacaine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000105	0.000592	CcSEcCtD
Levobupivacaine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000105	0.000592	CcSEcCtD
Levobupivacaine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000105	0.000592	CcSEcCtD
Levobupivacaine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000105	0.000591	CcSEcCtD
Levobupivacaine—Cough—Losartan—type 2 diabetes mellitus	0.000105	0.000588	CcSEcCtD
Levobupivacaine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000105	0.000588	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000105	0.000587	CcSEcCtD
Levobupivacaine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000104	0.000585	CcSEcCtD
Levobupivacaine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000104	0.000585	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000104	0.000585	CcSEcCtD
Levobupivacaine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000104	0.000585	CcSEcCtD
Levobupivacaine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000104	0.000584	CcSEcCtD
Levobupivacaine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000104	0.000583	CcSEcCtD
Levobupivacaine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000104	0.000582	CcSEcCtD
Levobupivacaine—Constipation—Valsartan—type 2 diabetes mellitus	0.000104	0.000582	CcSEcCtD
Levobupivacaine—Infection—Irbesartan—type 2 diabetes mellitus	0.000103	0.000581	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000103	0.00058	CcSEcCtD
Levobupivacaine—Hypotension—Metformin—type 2 diabetes mellitus	0.000103	0.000579	CcSEcCtD
Levobupivacaine—Erythema—Ramipril—type 2 diabetes mellitus	0.000103	0.000578	CcSEcCtD
Levobupivacaine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000103	0.000578	CcSEcCtD
Levobupivacaine—Shock—Irbesartan—type 2 diabetes mellitus	0.000102	0.000575	CcSEcCtD
Levobupivacaine—Pain—Orlistat—type 2 diabetes mellitus	0.000102	0.000575	CcSEcCtD
Levobupivacaine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000102	0.000574	CcSEcCtD
Levobupivacaine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000102	0.000574	CcSEcCtD
Levobupivacaine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000102	0.000573	CcSEcCtD
Levobupivacaine—Anxiety—Losartan—type 2 diabetes mellitus	0.000102	0.000572	CcSEcCtD
Levobupivacaine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000102	0.000571	CcSEcCtD
Levobupivacaine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000101	0.000568	CcSEcCtD
Levobupivacaine—Tension—Ramipril—type 2 diabetes mellitus	0.000101	0.000567	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000101	0.000565	CcSEcCtD
Levobupivacaine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000101	0.000565	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000101	0.000564	CcSEcCtD
Levobupivacaine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000101	0.000564	CcSEcCtD
Levobupivacaine—Nervousness—Ramipril—type 2 diabetes mellitus	0.0001	0.000561	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.91e-05	0.000556	CcSEcCtD
Levobupivacaine—Paraesthesia—Metformin—type 2 diabetes mellitus	9.91e-05	0.000556	CcSEcCtD
Levobupivacaine—Muscle spasms—Ramipril—type 2 diabetes mellitus	9.9e-05	0.000556	CcSEcCtD
Levobupivacaine—Confusional state—Losartan—type 2 diabetes mellitus	9.88e-05	0.000555	CcSEcCtD
Levobupivacaine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.87e-05	0.000554	CcSEcCtD
Levobupivacaine—Dyspnoea—Metformin—type 2 diabetes mellitus	9.84e-05	0.000552	CcSEcCtD
Levobupivacaine—Somnolence—Metformin—type 2 diabetes mellitus	9.81e-05	0.000551	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.8e-05	0.00055	CcSEcCtD
Levobupivacaine—Oedema—Losartan—type 2 diabetes mellitus	9.8e-05	0.00055	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.79e-05	0.00055	CcSEcCtD
Levobupivacaine—Infection—Losartan—type 2 diabetes mellitus	9.74e-05	0.000547	CcSEcCtD
Levobupivacaine—Hypotension—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000546	CcSEcCtD
Levobupivacaine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.72e-05	0.000546	CcSEcCtD
Levobupivacaine—Dyspepsia—Metformin—type 2 diabetes mellitus	9.71e-05	0.000545	CcSEcCtD
Levobupivacaine—Tremor—Ramipril—type 2 diabetes mellitus	9.65e-05	0.000542	CcSEcCtD
Levobupivacaine—Shock—Losartan—type 2 diabetes mellitus	9.64e-05	0.000541	CcSEcCtD
Levobupivacaine—Urticaria—Valsartan—type 2 diabetes mellitus	9.63e-05	0.00054	CcSEcCtD
Levobupivacaine—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.61e-05	0.00054	CcSEcCtD
Levobupivacaine—Decreased appetite—Metformin—type 2 diabetes mellitus	9.59e-05	0.000539	CcSEcCtD
Levobupivacaine—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.58e-05	0.000538	CcSEcCtD
Levobupivacaine—Tachycardia—Losartan—type 2 diabetes mellitus	9.57e-05	0.000537	CcSEcCtD
Levobupivacaine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.54e-05	0.000536	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.53e-05	0.000535	CcSEcCtD
Levobupivacaine—Urticaria—Orlistat—type 2 diabetes mellitus	9.51e-05	0.000534	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.000533	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.47e-05	0.000532	CcSEcCtD
Levobupivacaine—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.47e-05	0.000531	CcSEcCtD
Levobupivacaine—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.47e-05	0.000531	CcSEcCtD
Levobupivacaine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.46e-05	0.000531	CcSEcCtD
Levobupivacaine—Agitation—Ramipril—type 2 diabetes mellitus	9.46e-05	0.000531	CcSEcCtD
Levobupivacaine—Constipation—Metformin—type 2 diabetes mellitus	9.44e-05	0.00053	CcSEcCtD
Levobupivacaine—Angioedema—Ramipril—type 2 diabetes mellitus	9.41e-05	0.000528	CcSEcCtD
Levobupivacaine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.35e-05	0.000525	CcSEcCtD
Levobupivacaine—Vomiting—Glyburide—type 2 diabetes mellitus	9.34e-05	0.000524	CcSEcCtD
Levobupivacaine—Pruritus—Gliclazide—type 2 diabetes mellitus	9.33e-05	0.000524	CcSEcCtD
Levobupivacaine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.28e-05	0.000521	CcSEcCtD
Levobupivacaine—Somnolence—Irbesartan—type 2 diabetes mellitus	9.26e-05	0.00052	CcSEcCtD
Levobupivacaine—Syncope—Ramipril—type 2 diabetes mellitus	9.23e-05	0.000518	CcSEcCtD
Levobupivacaine—Headache—Glyburide—type 2 diabetes mellitus	9.2e-05	0.000517	CcSEcCtD
Levobupivacaine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.17e-05	0.000515	CcSEcCtD
Levobupivacaine—Hypotension—Losartan—type 2 diabetes mellitus	9.16e-05	0.000514	CcSEcCtD
Levobupivacaine—Palpitations—Ramipril—type 2 diabetes mellitus	9.1e-05	0.000511	CcSEcCtD
Levobupivacaine—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.09e-05	0.000511	CcSEcCtD
Levobupivacaine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000508	CcSEcCtD
Levobupivacaine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.05e-05	0.000508	CcSEcCtD
Levobupivacaine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.02e-05	0.000507	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.02e-05	0.000507	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000505	CcSEcCtD
Levobupivacaine—Cough—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000504	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.93e-05	0.000501	CcSEcCtD
Levobupivacaine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.93e-05	0.000501	CcSEcCtD
Levobupivacaine—Convulsion—Ramipril—type 2 diabetes mellitus	8.92e-05	0.000501	CcSEcCtD
Levobupivacaine—Pain—Irbesartan—type 2 diabetes mellitus	8.91e-05	0.0005	CcSEcCtD
Levobupivacaine—Constipation—Irbesartan—type 2 diabetes mellitus	8.91e-05	0.0005	CcSEcCtD
Levobupivacaine—Insomnia—Losartan—type 2 diabetes mellitus	8.86e-05	0.000498	CcSEcCtD
Levobupivacaine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.82e-05	0.000495	CcSEcCtD
Levobupivacaine—Paraesthesia—Losartan—type 2 diabetes mellitus	8.8e-05	0.000494	CcSEcCtD
Levobupivacaine—Urticaria—Metformin—type 2 diabetes mellitus	8.77e-05	0.000492	CcSEcCtD
Levobupivacaine—Arthralgia—Ramipril—type 2 diabetes mellitus	8.77e-05	0.000492	CcSEcCtD
Levobupivacaine—Dyspnoea—Losartan—type 2 diabetes mellitus	8.74e-05	0.000491	CcSEcCtD
Levobupivacaine—Anxiety—Ramipril—type 2 diabetes mellitus	8.74e-05	0.00049	CcSEcCtD
Levobupivacaine—Nausea—Glyburide—type 2 diabetes mellitus	8.73e-05	0.00049	CcSEcCtD
Levobupivacaine—Abdominal pain—Metformin—type 2 diabetes mellitus	8.72e-05	0.00049	CcSEcCtD
Levobupivacaine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.72e-05	0.00049	CcSEcCtD
Levobupivacaine—Somnolence—Losartan—type 2 diabetes mellitus	8.71e-05	0.000489	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000489	CcSEcCtD
Levobupivacaine—Asthenia—Valsartan—type 2 diabetes mellitus	8.69e-05	0.000488	CcSEcCtD
Levobupivacaine—Dyspepsia—Losartan—type 2 diabetes mellitus	8.63e-05	0.000484	CcSEcCtD
Levobupivacaine—Asthenia—Orlistat—type 2 diabetes mellitus	8.59e-05	0.000482	CcSEcCtD
Levobupivacaine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.58e-05	0.000482	CcSEcCtD
Levobupivacaine—Pruritus—Valsartan—type 2 diabetes mellitus	8.57e-05	0.000481	CcSEcCtD
Levobupivacaine—Decreased appetite—Losartan—type 2 diabetes mellitus	8.52e-05	0.000478	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.52e-05	0.000478	CcSEcCtD
Levobupivacaine—Confusional state—Ramipril—type 2 diabetes mellitus	8.47e-05	0.000476	CcSEcCtD
Levobupivacaine—Pruritus—Orlistat—type 2 diabetes mellitus	8.47e-05	0.000476	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000472	CcSEcCtD
Levobupivacaine—Oedema—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000472	CcSEcCtD
Levobupivacaine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.39e-05	0.000471	CcSEcCtD
Levobupivacaine—Pain—Losartan—type 2 diabetes mellitus	8.38e-05	0.000471	CcSEcCtD
Levobupivacaine—Constipation—Losartan—type 2 diabetes mellitus	8.38e-05	0.000471	CcSEcCtD
Levobupivacaine—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.29e-05	0.000466	CcSEcCtD
Levobupivacaine—Urticaria—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000464	CcSEcCtD
Levobupivacaine—Shock—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000464	CcSEcCtD
Levobupivacaine—Headache—Gliclazide—type 2 diabetes mellitus	8.26e-05	0.000464	CcSEcCtD
Levobupivacaine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.24e-05	0.000463	CcSEcCtD
Levobupivacaine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.23e-05	0.000462	CcSEcCtD
Levobupivacaine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.23e-05	0.000462	CcSEcCtD
Levobupivacaine—Tachycardia—Ramipril—type 2 diabetes mellitus	8.2e-05	0.00046	CcSEcCtD
Levobupivacaine—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.19e-05	0.00046	CcSEcCtD
Levobupivacaine—Skin disorder—Ramipril—type 2 diabetes mellitus	8.16e-05	0.000458	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000456	CcSEcCtD
Levobupivacaine—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.08e-05	0.000453	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.01e-05	0.00045	CcSEcCtD
Levobupivacaine—Dizziness—Valsartan—type 2 diabetes mellitus	8.01e-05	0.00045	CcSEcCtD
Levobupivacaine—Dizziness—Orlistat—type 2 diabetes mellitus	7.92e-05	0.000445	CcSEcCtD
Levobupivacaine—Asthenia—Metformin—type 2 diabetes mellitus	7.92e-05	0.000445	CcSEcCtD
Levobupivacaine—Hypotension—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000441	CcSEcCtD
Levobupivacaine—Nausea—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.00044	CcSEcCtD
Levobupivacaine—Pruritus—Metformin—type 2 diabetes mellitus	7.81e-05	0.000438	CcSEcCtD
Levobupivacaine—Urticaria—Losartan—type 2 diabetes mellitus	7.79e-05	0.000437	CcSEcCtD
Levobupivacaine—Body temperature increased—Losartan—type 2 diabetes mellitus	7.75e-05	0.000435	CcSEcCtD
Levobupivacaine—Abdominal pain—Losartan—type 2 diabetes mellitus	7.75e-05	0.000435	CcSEcCtD
Levobupivacaine—Vomiting—Valsartan—type 2 diabetes mellitus	7.7e-05	0.000433	CcSEcCtD
Levobupivacaine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.67e-05	0.000431	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.66e-05	0.00043	CcSEcCtD
Levobupivacaine—Vomiting—Orlistat—type 2 diabetes mellitus	7.61e-05	0.000427	CcSEcCtD
Levobupivacaine—Insomnia—Ramipril—type 2 diabetes mellitus	7.6e-05	0.000427	CcSEcCtD
Levobupivacaine—Headache—Valsartan—type 2 diabetes mellitus	7.59e-05	0.000426	CcSEcCtD
Levobupivacaine—Diarrhoea—Metformin—type 2 diabetes mellitus	7.55e-05	0.000424	CcSEcCtD
Levobupivacaine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.55e-05	0.000424	CcSEcCtD
Levobupivacaine—Headache—Orlistat—type 2 diabetes mellitus	7.5e-05	0.000421	CcSEcCtD
Levobupivacaine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000421	CcSEcCtD
Levobupivacaine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.47e-05	0.000419	CcSEcCtD
Levobupivacaine—Somnolence—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000419	CcSEcCtD
Levobupivacaine—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.4e-05	0.000415	CcSEcCtD
Levobupivacaine—Pruritus—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.000414	CcSEcCtD
Levobupivacaine—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.31e-05	0.00041	CcSEcCtD
Levobupivacaine—Dizziness—Metformin—type 2 diabetes mellitus	7.3e-05	0.00041	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.26e-05	0.000407	CcSEcCtD
Levobupivacaine—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.22e-05	0.000405	CcSEcCtD
Levobupivacaine—Nausea—Valsartan—type 2 diabetes mellitus	7.2e-05	0.000404	CcSEcCtD
Levobupivacaine—Constipation—Ramipril—type 2 diabetes mellitus	7.19e-05	0.000403	CcSEcCtD
Levobupivacaine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.13e-05	0.0004	CcSEcCtD
Levobupivacaine—Nausea—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000399	CcSEcCtD
Levobupivacaine—Asthenia—Losartan—type 2 diabetes mellitus	7.03e-05	0.000395	CcSEcCtD
Levobupivacaine—Vomiting—Metformin—type 2 diabetes mellitus	7.02e-05	0.000394	CcSEcCtD
Levobupivacaine—Pruritus—Losartan—type 2 diabetes mellitus	6.93e-05	0.000389	CcSEcCtD
Levobupivacaine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.93e-05	0.000389	CcSEcCtD
Levobupivacaine—Headache—Metformin—type 2 diabetes mellitus	6.91e-05	0.000388	CcSEcCtD
Levobupivacaine—Dizziness—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.000387	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000386	CcSEcCtD
Levobupivacaine—Diarrhoea—Losartan—type 2 diabetes mellitus	6.71e-05	0.000376	CcSEcCtD
Levobupivacaine—Urticaria—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000375	CcSEcCtD
Levobupivacaine—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000373	CcSEcCtD
Levobupivacaine—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.64e-05	0.000373	CcSEcCtD
Levobupivacaine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.62e-05	0.000372	CcSEcCtD
Levobupivacaine—Nausea—Metformin—type 2 diabetes mellitus	6.55e-05	0.000368	CcSEcCtD
Levobupivacaine—Headache—Irbesartan—type 2 diabetes mellitus	6.52e-05	0.000366	CcSEcCtD
Levobupivacaine—Dizziness—Losartan—type 2 diabetes mellitus	6.48e-05	0.000364	CcSEcCtD
Levobupivacaine—Vomiting—Losartan—type 2 diabetes mellitus	6.23e-05	0.00035	CcSEcCtD
Levobupivacaine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000348	CcSEcCtD
Levobupivacaine—Nausea—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000347	CcSEcCtD
Levobupivacaine—Headache—Losartan—type 2 diabetes mellitus	6.14e-05	0.000345	CcSEcCtD
Levobupivacaine—Asthenia—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000339	CcSEcCtD
Levobupivacaine—Pruritus—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000334	CcSEcCtD
Levobupivacaine—Nausea—Losartan—type 2 diabetes mellitus	5.82e-05	0.000327	CcSEcCtD
Levobupivacaine—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000323	CcSEcCtD
Levobupivacaine—Dizziness—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000312	CcSEcCtD
Levobupivacaine—Vomiting—Ramipril—type 2 diabetes mellitus	5.34e-05	0.0003	CcSEcCtD
Levobupivacaine—Headache—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000296	CcSEcCtD
Levobupivacaine—Nausea—Ramipril—type 2 diabetes mellitus	4.99e-05	0.00028	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—MMP9—type 2 diabetes mellitus	4.74e-05	0.000972	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.72e-05	0.000968	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.65e-05	0.000954	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT2—type 2 diabetes mellitus	4.65e-05	0.000953	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—SRC—type 2 diabetes mellitus	4.53e-05	0.00093	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	4.47e-05	0.000917	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	4.42e-05	0.000906	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—VEGFA—type 2 diabetes mellitus	4.41e-05	0.000906	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—SRC—type 2 diabetes mellitus	4.37e-05	0.000897	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—VEGFA—type 2 diabetes mellitus	4.26e-05	0.000873	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	4.19e-05	0.000859	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—type 2 diabetes mellitus	4.15e-05	0.000851	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—RELA—type 2 diabetes mellitus	4.12e-05	0.000844	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—EGFR—type 2 diabetes mellitus	3.97e-05	0.000815	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—RELA—type 2 diabetes mellitus	3.97e-05	0.000814	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.89e-05	0.000799	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—type 2 diabetes mellitus	3.86e-05	0.000793	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—type 2 diabetes mellitus	3.86e-05	0.000793	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.84e-05	0.000788	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—EGFR—type 2 diabetes mellitus	3.83e-05	0.000786	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—type 2 diabetes mellitus	3.76e-05	0.000772	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	3.76e-05	0.000771	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP3A4—type 2 diabetes mellitus	3.75e-05	0.00077	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	3.7e-05	0.00076	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	3.64e-05	0.000747	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	3.59e-05	0.000736	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MMP9—type 2 diabetes mellitus	3.51e-05	0.00072	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—NFKB1—type 2 diabetes mellitus	3.47e-05	0.000712	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—type 2 diabetes mellitus	3.45e-05	0.000709	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 2 diabetes mellitus	3.39e-05	0.000695	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 2 diabetes mellitus	3.39e-05	0.000695	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—MMP9—type 2 diabetes mellitus	3.38e-05	0.000694	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—NFKB1—type 2 diabetes mellitus	3.35e-05	0.000687	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	3.26e-05	0.000668	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—SRC—type 2 diabetes mellitus	3.23e-05	0.000664	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 2 diabetes mellitus	3.22e-05	0.000662	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 2 diabetes mellitus	3.22e-05	0.000662	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	3.17e-05	0.000651	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—VEGFA—type 2 diabetes mellitus	3.15e-05	0.000646	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—SRC—type 2 diabetes mellitus	3.12e-05	0.00064	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—IL6—type 2 diabetes mellitus	3.05e-05	0.000626	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—VEGFA—type 2 diabetes mellitus	3.04e-05	0.000623	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	3.03e-05	0.000621	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	3.03e-05	0.000621	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	3.03e-05	0.000621	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3e-05	0.000616	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	2.97e-05	0.000609	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.96e-05	0.000608	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.95e-05	0.000605	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—IL6—type 2 diabetes mellitus	2.94e-05	0.000604	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	2.93e-05	0.000601	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.91e-05	0.000597	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—TGFB1—type 2 diabetes mellitus	2.89e-05	0.000593	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—EGFR—type 2 diabetes mellitus	2.83e-05	0.000582	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TGFB1—type 2 diabetes mellitus	2.79e-05	0.000572	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	2.74e-05	0.000563	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—EGFR—type 2 diabetes mellitus	2.73e-05	0.000561	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—TNF—type 2 diabetes mellitus	2.7e-05	0.000554	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	2.7e-05	0.000553	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TNF—type 2 diabetes mellitus	2.6e-05	0.000534	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	2.29e-05	0.000471	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	2.29e-05	0.000471	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.28e-05	0.000467	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	2.25e-05	0.000462	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.25e-05	0.000461	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IL6—type 2 diabetes mellitus	2.18e-05	0.000447	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—IL6—type 2 diabetes mellitus	2.1e-05	0.000431	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—AKT1—type 2 diabetes mellitus	2.01e-05	0.000412	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	1.97e-05	0.000404	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.97e-05	0.000404	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT1—type 2 diabetes mellitus	1.94e-05	0.000398	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.87e-05	0.000384	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.86e-05	0.000383	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.86e-05	0.000383	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.82e-05	0.000374	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.81e-05	0.000372	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.78e-05	0.000365	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.76e-05	0.000361	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.74e-05	0.000356	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.64e-05	0.000337	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.64e-05	0.000337	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.63e-05	0.000335	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.6e-05	0.000329	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.59e-05	0.000326	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	1.59e-05	0.000325	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	1.59e-05	0.000325	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	1.59e-05	0.000325	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	1.59e-05	0.000325	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.59e-05	0.000325	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.54e-05	0.000315	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.52e-05	0.000311	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.52e-05	0.000311	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.45e-05	0.000297	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.45e-05	0.000297	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.44e-05	0.000295	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.44e-05	0.000295	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.41e-05	0.00029	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.37e-05	0.000282	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.35e-05	0.000277	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.35e-05	0.000277	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.35e-05	0.000277	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.29e-05	0.000265	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.29e-05	0.000265	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.27e-05	0.00026	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.27e-05	0.00026	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.24e-05	0.000255	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.24e-05	0.000255	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.22e-05	0.000251	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.22e-05	0.000251	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.22e-05	0.000251	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.22e-05	0.000251	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.22e-05	0.000251	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.22e-05	0.000251	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.22e-05	0.000251	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.2e-05	0.000246	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.2e-05	0.000246	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.2e-05	0.000246	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.18e-05	0.000243	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.16e-05	0.000239	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	1.13e-05	0.000232	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.12e-05	0.00023	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.12e-05	0.00023	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.11e-05	0.000228	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.09e-05	0.000224	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.08e-05	0.000223	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	1.06e-05	0.000217	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.06e-05	0.000217	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.04e-05	0.000213	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.04e-05	0.000213	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.04e-05	0.000213	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	1.02e-05	0.00021	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.02e-05	0.00021	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	1.02e-05	0.00021	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.02e-05	0.00021	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.97e-06	0.000205	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.97e-06	0.000205	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.82e-06	0.000202	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	9.79e-06	0.000201	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	9.6e-06	0.000197	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	9.6e-06	0.000197	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.51e-06	0.000195	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.43e-06	0.000193	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.32e-06	0.000191	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	9.27e-06	0.00019	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	9.27e-06	0.00019	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	9.27e-06	0.00019	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.21e-06	0.000189	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	9.1e-06	0.000187	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.72e-06	0.000179	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	8.5e-06	0.000174	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	8.33e-06	0.000171	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	8.33e-06	0.000171	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	8.17e-06	0.000168	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	8.16e-06	0.000167	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.12e-06	0.000167	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	8.11e-06	0.000166	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	8.11e-06	0.000166	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	8.11e-06	0.000166	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	8.06e-06	0.000165	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	7.92e-06	0.000163	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.88e-06	0.000162	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.88e-06	0.000162	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.88e-06	0.000162	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.88e-06	0.000162	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	7.83e-06	0.000161	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.56e-06	0.000155	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.3e-06	0.00015	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	7.28e-06	0.000149	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	7.28e-06	0.000149	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	7.28e-06	0.000149	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	7.14e-06	0.000147	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	7.08e-06	0.000145	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.03e-06	0.000144	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.98e-06	0.000143	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	6.93e-06	0.000142	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	6.66e-06	0.000137	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	6.58e-06	0.000135	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.56e-06	0.000135	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.43e-06	0.000132	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.43e-06	0.000132	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.42e-06	0.000132	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.39e-06	0.000131	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.31e-06	0.000129	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	6.31e-06	0.000129	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.3e-06	0.000129	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.26e-06	0.000128	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.26e-06	0.000128	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.26e-06	0.000128	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.22e-06	0.000128	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.11e-06	0.000125	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.04e-06	0.000124	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.62e-06	0.000115	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.62e-06	0.000115	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.62e-06	0.000115	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.51e-06	0.000113	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.46e-06	0.000112	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	5.44e-06	0.000112	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.44e-06	0.000112	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.41e-06	0.000111	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.35e-06	0.00011	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	5.34e-06	0.00011	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	5.19e-06	0.000106	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.14e-06	0.000105	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.08e-06	0.000104	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.08e-06	0.000104	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	5.05e-06	0.000104	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.95e-06	0.000102	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.87e-06	9.99e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.87e-06	9.99e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.85e-06	9.95e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.83e-06	9.91e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.71e-06	9.65e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.65e-06	9.53e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.46e-06	9.15e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	4.37e-06	8.98e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	4.24e-06	8.69e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.2e-06	8.61e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.2e-06	8.61e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.18e-06	8.57e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	4.17e-06	8.55e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	4.15e-06	8.52e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.12e-06	8.46e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	4.1e-06	8.42e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4e-06	8.21e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.89e-06	7.99e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.82e-06	7.84e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.74e-06	7.68e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.73e-06	7.65e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.63e-06	7.45e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.62e-06	7.42e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.59e-06	7.36e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.55e-06	7.28e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.44e-06	7.06e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.38e-06	6.93e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.27e-06	6.71e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	3.25e-06	6.67e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.21e-06	6.6e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.2e-06	6.57e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.17e-06	6.5e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.11e-06	6.38e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	3.11e-06	6.38e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.84e-06	5.84e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.79e-06	5.73e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.74e-06	5.62e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.51e-06	5.15e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.4e-06	4.92e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.4e-06	4.92e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.2e-06	4.5e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.43e-06	2.93e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	2.26e-05	CbGpPWpGaD
